Copyright
©The Author(s) 2019.
World J Clin Cases. Jan 26, 2019; 7(2): 171-190
Published online Jan 26, 2019. doi: 10.12998/wjcc.v7.i2.171
Published online Jan 26, 2019. doi: 10.12998/wjcc.v7.i2.171
Ref. | Period | Country | Sample Size | Cancer Type | Stage | Sample | Isolation method of exosome | Marker | Detection method | Cut-off value | Survival analysis | HR (95%CI) |
Peng et al[65] | 2008-2014 | China | 108 | Colorectal | All | Serum | Total exosome isolation kit | miR-548c-5p | qRT-PCR | NR | OS | 3.40 (1.02‐11.27) |
Sun et al[35] | 2012-2017 | China | 92 | Colorectal | All | Plasma | UC | CPNE3 | ELISA | ≥ 0.143 pg/μg exosome | OS | 3.0 (1.0-8.9) |
≥ 0.143 pg/μg exosome | DFS | 2.5 (1.1-5.5) | ||||||||||
Tsukamoto et al[66] | 2002-2012 | Japan | 326 | Colorectal | II-IV | Plasma | UC | miR-21 | qRT-PCR | > median | OS | 2.28 (1.81-5.74) |
DFS | 2.34 (1.87- 4.60) | |||||||||||
Liu et al[37] | 2007-2010 | China | 148 | Colorectal | All | Serum | ExoQuick | CRNDE-h | qRT-PCR | > 0.02 | OS | 2.000 (1.269-3.154) |
Liu et al[67] | 2006-2011 | United States | 84 | Colorectal | II-III | Serum | ExoQuick | miR-4772-3p | qRT-PCR | ≥ 27.88 | OS | 6.19 (1.50-25.5) |
≥ 27.88 | RFS | 5.48 (2.49-12.1) | ||||||||||
Liu et al[24] | 2013-2014 | China | 158 | Colorectal | All | Plasma | UC | lncRNA GAS5 | qRT-PCR | NR | OS | 0.265 (0.082 -0.844) |
RFS | 0.449 (0.194- 0.909) | |||||||||||
miR-221 | qRT-PCR | NR | OS | 2.141 (1.368-3.054) | ||||||||
RFS | 1.600 (1.162-2.007) | |||||||||||
Gao et al[68] | 2011-2014 | China | 108 | Colorectal | All | Serum | ExoQuick | 91H | qRT-PCR | ≥ 0.85 | RFS | 7.14 (1.23-21.35) |
Yan et al[69] | NR | NR | 168 | Colorectal | All | Serum | Total Exosome Isolation kit | miR-6803 | qRT-PCR | NR | OS | 2.93 (1.35-6.37) |
DFS | 3.26 (1.56-6.81) | |||||||||||
Li et al[70] | 2013-2015 | China | 85 | Colorectal | III | Plasma | ExoCapTM | GPC1 | Flow cytometry | > mean | OS | 1.89 (1.23-2.89) |
Silva et al[71] | 2003-2009 | Spain | 91 | Colorectal | All | Plasma | UC | Exosome | Flow cytometry of EpCAM | High | OS | 0.87 (0.57-1.32) |
Matsumura et al[72] | 1992-2007 | Japan | 209 | Colorectal | All | Serum | UC | miR-19 | qRT-PCR | > mean | O | 2.49 (1.12-6.61) |
DFS | 2.49 (1.12-6.61) | |||||||||||
Yan et al[73] | 2012-2015 | China | 142 | Colorectal | All | Serum | Total Exosome Isolation kit | miR-6869-5p | qRT-PCR | < mean | OS | 2.32 (1.08-4.99) |
Santasusagna et al[25] | 2009-2013 | Spain | 32 | Colon | I-III | Plasma | UC | miR-141 | qRT-PCR | High | OS | 1.89 (0.93-3.83) |
Zhao et al[40] | 2011-2012 | China | 126 | Gastric | All | Serum | NR | HOTTIP | qRT-PCR | > 1.72 | OS | 2.037 (1.085-3.823) |
Liu et al[74] | 2012-2017 | China | 76 | Gastric | All | Serum | Total Exosome Isolation kit | miR-451 | qRT-PCR | > median | 5yr-OS | 4.344 (2.853‐5.721) |
Yang et al[42] | NR | China | 80 | Gastric | All | Serum | ExoQuick | miR-423-5p | qRT-PCR | > median | DFS | 1.93 (1.25-2.99) |
OS | 1.42 (0.92-2.20) | |||||||||||
Kumata et al[75] | 2006-2013 | Japan | 232 | Gastric | All | Plasma | UC | miR23b | qRT-PCR | > 0.78 | OS | 0.57 (0.370.78) |
DFS | 0.64 (0.410.91) | |||||||||||
Zhou et al[76] | 2010-2014 | China | 152 | Pancreatic | All | Plasma | ExoQuick | miR-125b-5p | qRT-PCR | < median | OS | 0.285 (0.108-0.75) |
Li et al[77] | 2012-2016 | China | 87 | Pancreatic | All | Plasma | NR | circPDE8A | qRT-PCR | > median | OS | 1.764 (1.064-2.925) |
Goto et al[43] | 2013-2015 | Japan | 32 | Pancreatic | All | Serum | ExoQuick | miR-21 | qRT-PCR | > median | OS | 4.071 (1.832-11.996) |
Takahasi et al[78] | 2013-2017 | Japan | 50 | Pancreatic | I-II | Plasma | UC | miR-451a | qRT-PCR | > 1.75 | OS | 3.20 (1.07-11.94) |
DFS | 2.87 (1.23-7.23) | |||||||||||
Xu et al[49] | 2012-2016 | China | 60 | Liver | All | Serum | Total Exosome Isolation kit | ENSG00000258332.1 | qRT-PCR | > 1.845 | OS | 2.22 (1.34-3.68) |
LINC00635 | qRT-PCR | > 2.100 | OS | 1.46 (0.88-2.43) | ||||||||
Shi et al[79] | 2008-2011 | China | 126 | Liver | All | Serum | Total Exosome Isolation kit | miR-638 | qRT-PCR | NR | 3yr-OS | 3.52 (1.37-6.02) |
5yr-OS | 2.80 (1.24-4.31) | |||||||||||
Liu et al[26] | 2012 | China | 128 | Liver | All | Serum | ExoQuick | miR-125b | qRT-PCR | < median | RFS | 0.14 (0.07-0.29) |
OS | 0.36 (0.18-0.74) | |||||||||||
Xue et al[80] | 2015-2017 | China | 85 | Liver | All | Serum | Total Exosome Isolation kit | miR-93 | qRT-PCR | NR | OS | 1.47 (0.96-2.25) |
Liu et al[81] | 2008-2013 | China | 32 | Hepatoblastoma (children) | All | Serum | ExoQuick | miR-21 | qRT-PCR | NR | EFS | 1.434 (1.257-2.766) |
Matsumoto et al[82] | 2011-2012 | Japan | 66 | Esophageal | All | Plasma | Total Exosome Isolation kit | exosome | AChE activity | < 600 x 108/mL | OS | 2.177 (1.085-3.605) |
Lu et al[83] | 2007-2015 | China | 110 | Nasopharyngeal | All | Plasma | UC | miR-9 | qRT-PCR | NR | OS | 1.5 (1.03-2.18) |
Ye et al[84] | 2011-2013 | China | 83 | Nasopharyngeal | II-IV | Serum | UC | protein concentration | BCA assay | > 11 μg/mL | DFS | 214.22 (139.27-329.49) |
Huang et al[85] | NR | NR | 23 | Prostate | All | Plasma | ExoQuick | miR-1290 | qRT-PCR | > mean | OS | 1.79(1.30-2.48) |
miR-375 | qRT-PCR | > mean | OS | 2.69(1.52-4.77) | ||||||||
Tang et al[86] | NR | NR | 35 | Ovarian | All | Ascitic fluid | UC | E-cadherin | NR | > 10 μg/mL | OS | 1.82 (0.53-3.58) |
Vaksman et al[87] | 1998-2003 | 86 | Ovarian | III-IV | Effusion supernatant | ExoQuick | miR-21 | qRT-PCR | > median | OS | 1.70 (1.1-2.59) | |
Kanaoka et al[88] | 2012-2017 | Japan | 285 | Lung | I-III | Plasma | UC | miR-451a | qRT-PCR | > 1.45 | OS | 6.06 (2.61-15.94) |
DFS | 2.55 (1.44-4.65) | |||||||||||
Liu et al[89] | 2012-2014 | China | 196 | Lung | All | Plasma | ExoQuick | miR-23b-3p | qRT-PCR | High | OS | 2.42 (1.45-4.04) |
miR-21-5p | qRT-PCR | OS | 2.12(1.28-3.49) | |||||||||
miR-10b-5p | qRT-PCR | OS | 2.22 (1.18-4.16) | |||||||||
Liu et al[90] | 2012-2014 | China | 208 | Lung | All | Plasma | ExoQuick | Exosome | AChE activity | OS | 1.72 (1.05-2.83) | |
Sandfeld-Paulsen et al[91] | 2011-2014 | Denmark | 276 | Lung | All | Plasma | / | CD171 | ELISA | NR | OS | 0.56 (0.41-0.79) |
Flotilin1 | ELISA | NR | OS | 0.63 (0.46-0.86) | ||||||||
HER3 | ELISA | NR | OS | 0.63 (0.46-0.86) | ||||||||
GRP78 | ELISA | NR | OS | 0.69 (0.51-0.91) | ||||||||
Manier et al[92] | 2006-2008 | France | 156 | Multiple myeloma | All | Plasma | ExoQuick | let-7b | qRT-PCR | < median | OS | 2.83 (1.07-7.50) |
let-7b | qRT-PCR | < median | DFS | 1.90 (1.22-2.94) | ||||||||
let-7e | qRT-PCR | < median | DFS | 2.01 (1.30-3.11) | ||||||||
miR-106a | qRT-PCR | < median | DFS | 2.34 (1.52-3.61) | ||||||||
miR-106b | qRT-PCR | < median | DFS | 3.54 (2.21-5.68) | ||||||||
miR-155 | qRT-PCR | < median | OS | 2.41 (0.96-6.05) | ||||||||
miR-155 | qRT-PCR | < median | DFS | 1.76 (1.15-2.69) | ||||||||
miR-16 | qRT-PCR | < median | DFS | 2.21 (1.41-3.47) | ||||||||
miR-17 | qRT-PCR | < median | DFS | 2.29 (1.48-3.55) | ||||||||
miR-18a | qRT-PCR | < median | DFS | 4.52 (1.57-12.98) | ||||||||
miR-18a | qRT-PCR | < median | OS | 2.76 (1.79-4.26) | ||||||||
miR-20a | qRT-PCR | < median | DFS | 2.31 (1.52-3.53) | ||||||||
Alegre et al[61] | NR | NR | 53 | Melanoma | NR | Serum | ExoQuick | MIA | ELISA | 2.5 μg/L | OS | 1.28 (0.65-2.51) |
Lan et al[93] | 2011-2012 | China | 60 | Glioma | All | Serum | ExoQuick | miR-301a | qRT-PCR | >median | OS | 4.4 (3.1-9.6) |
Ge et al[64] | NR | China | 35 | Cholangiocarcinoma | All | Bile | UC | ENST00000588480.1 | qRT-PCR | > median | OS | 2.40 (1.24-4.66) |
ENST00000517758.1 | qRT-PCR | OS | 1.55 (0.80-3.01) | |||||||||
Fujii et al[94] | 2005-2014 | Japan | 108 | Renal cell | I-III | Serum | Total Exosome Isolation kit | miR-224 | qRT-PCR | > median | OS | 9.1 (1.8-166.1) |
- Citation: Wong CH, Chen YC. Clinical significance of exosomes as potential biomarkers in cancer. World J Clin Cases 2019; 7(2): 171-190
- URL: https://www.wjgnet.com/2307-8960/full/v7/i2/171.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i2.171